Argenica Therapeutics Shares Insights at the ASX Small and Mid-Cap Conference | Liz Dallimore, CEO , Argenica Therapeutics Ltd. 00:10:00

Share On Facebook Share On Twitter

Dr. Liz Dallimore is the CEO and Managing Director of Argenica Therapeutics, an Australian biotech company focused on advancing therapies for neurological diseases. With over 20 years of experience in both biotechnology and management consulting, Dr. Dallimore has held prominent roles at organizations like KPMG, Ernst & Young, and PricewaterhouseCoopers. She has a strong background in technology commercialization, particularly in the biotech sector.

Recent Videos